Dean C. Bachus

Partner

Chicago + 1.312.269.4220

Connect:

Share

For nearly 20 years, Dean Bachus has focused his practice on executive compensation, benefits, and Employee Retirement Income Security Act (ERISA) transactional matters. His experience covers tax planning and structuring compensation and benefit arrangements in domestic and international business acquisitions and dispositions. He also advises clients in connection with all compensation and employee benefit-related aspects of corporate transactions, reorganizations, financing arrangements, and public offerings, including negotiating, reviewing, and drafting transactional documents, supervising due diligence, and identifying issues arising under, and assisting in complying with, the Internal Revenue Code, ERISA, applicable labor laws, federal securities laws, and applicable exchange regulations.

Dean's practice includes designing, negotiating, and drafting equity-based compensation plans (including stock option, restricted stock, and phantom equity arrangements); cash bonus plans; employment, consulting, termination, severance, and change-in-control contracts; and restrictive covenant agreements, including noncompetition, nonsolicitation, and confidentiality arrangements.

Dean also advises clients on the structure, implementation, and administration of nonqualified employee compensation plans, programs, and arrangements, including the associated ERISA, federal tax, and securities implications. He also provides counsel to management teams and boards of directors on executive compensation and change-in-control arrangements in connection with corporate transactions and reorganizations and consults with shareholders, senior executives, and boards of directors on transactional strategies.

Dean has represented major private equity funds and publicly traded companies in hundreds of acquisitions and dispositions, focusing on benefit and compensation issues that arise in such transactions, as well as the design and maintenance of incentive programs and facilitating management turnover.

Experience

  • Wells Fargo amends and restates $4 billion senior unsecured revolving credit facility for publicly traded real estate investment trustJones Day represented Wells Fargo Bank, National Association, as administrative agent, in connection with the amendment and restatement of a $4 billion senior unsecured revolving credit facility for a publicly traded real estate investment trust.
  • Wells Fargo-led syndicate provides $1.38 billion senior unsecured credit agreement to subsidiary of publicly traded real estate investment trustJones Day represented Wells Fargo Bank, National Association, as administrative agent, in connection with a $1.38 billion senior unsecured credit agreement, consisting of a $1 billion revolving credit facility and a $380 million delayed draw term loan facility, to a subsidiary of a publicly traded real estate investment trust.
  • Urban Elevator sells eight locations to OtisJones Day advised Urban Elevator in the sale of eight locations to Otis Elevator Company.
  • Large financial institution provides $1.115 billion senior secured credit facilities to national mortgage lender and servicerJones Day advised a large financial institution, as administrative agent, in connection with a refinancing of an existing facility to a national mortgage lender and servicer, resulting in a total credit facility of $1.115 billion, including a term loan facility in an aggregate principal amount of $400 million and a revolving commitment in an aggregate principal amount of $715 million.
  • Wells Fargo provides $163 million term loan secured by Class-A office tower located in San Francisco's "AI Corridor"Jones Day represented Wells Fargo Bank, National Association in connection with a $163 million term loan secured by a Class-A office tower located in San Francisco's "AI Corridor".
  • Financial institution provides $132.8 million term loan secured by property in ChicagoJones Day represented a large financial institution, as administrative agent, in connection with a $132.8 million term loan secured by a mixed-used property in Chicago, Illinois consisting of luxury apartments and retail space.
  • Artis BioSolutions acquires Landmark BioJones Day advised Artis BioSolutions, a newly launched company dedicated to streamlining the discovery, process development, and manufacturing of genetic medicines, in its acquisition of Landmark Bio, allowing expansion of manufacturing and commercialization of advanced therapies.
  • Golden Gate Capital completes sale of Stonehill Environmental PartnersJones Day advised Stonehill Environmental Partners in the sale of Stonehill by Golden Gate Capital, a San Francisco-based private equity firm.
  • ABM amends and extends its $2.2 billion credit facilityJones Day advised ABM Industries Incorporated (NYSE: ABM), a leading provider of facility solutions, in connection with an amendment and extension to its existing credit facility with Bank of America, N.A., as administrative agent, which provides for an aggregate principal amount of commitments under the dollar and multicurrency revolving credit facilities of $1.6 billion and an aggregate principal amount of commitments under the term facility of $600 million.
  • Everberg Capital Partners III, L.P. and affiliated funds obtain subscription line credit facilityJones Day represented Everberg Capital Partners III, L.P. and its affiliated funds on a new subscription line credit facility with Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, as the lender.
  • OTC Industrial Technologies acquires Premier Equipment Corporation and Premier Control SystemsJones Day advised OTC Industrial Technologies in the acquisition of Premier Equipment Corporation, Inc. (PEC), a leading distributor of rotating equipment, and Premier Control Systems, LLC, a prominent design and fabrication provider of control panels.
  • Bil-Jac Foods receives investment from Entrepreneurial Equity PartnersJones Day represented Bil-Jac Foods, Inc. (Bil-Jac), an Ohio-based leading manufacturer of dog food and treats, in connection with an investment in Bil-Jac by Entrepreneurial Equity Partners, a Chicago, Illinois, based private equity firm.
  • Lam Research amends and restates its existing revolving credit facility to $2 billionJones Day represented Lam Research Corporation, a global developer and supplier of semiconductor manufacturing equipment, in connection with its $2 billion amended and restated revolving credit facility.
  • OEConnection acquires PartsTechJones Day advised OEConnection in the acquisition of PartsTech, Inc., an auto parts procurement platform for mechanical repair shops.
  • Barings Direct and MassMutual negotiate and document €150 million revolving credit facility provided to Luxembourg SPV, managed by leading global investment firmJones Day represented Barings Direct Investments LLC, as servicer, and Massachusetts Mutual Life Insurance Company and MassMutual Ascend Life Insurance Company, as lenders, in negotiating and documenting a €150 million revolving credit facility provided to a Luxembourg special purpose vehicle under the management of a leading global investment firm, with Alter Domus Agency Services (UK) Limited and Alter Domus Trustees (UK) Limited serving as administrative agent and collateral agent, respectively.
  • Resonant Growth Partners acquires Midwest FastenersJones Day advised Resonant Growth Partners LLC in the acquisition and financing of Midwest Fasteners, Inc., a leading hardware supplier and manufacturer.
  • Citibank provides multicurrency secured credit facility to Tanks US Buyer Inc. and Tanks International Buyer B.V.Jones Day represented Citibank, N.A., as administrative agent, joint lead arranger, and joint bookrunner, in connection with a $295 million secured multicurrency letter of credit and revolving credit facility provided to Tanks US Buyer Inc. and Tanks International Buyer B.V.
  • Large financial institution arranges $1.85 billion multicurrency credit facility for real estate investment fundJones Day represented a large financial institution, as administrative agent, in connection with a $1.85 billion unsecured credit facility, consisting of a US$825 million revolving credit facility, a CA$175 million alternative currency revolving credit facility, and a US$850 million term loan facility, provided to a real estate investment fund.
  • Reneo Pharmaceuticals announces reverse merger with OnKureJones Day represented Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) in an all-stock reverse merger between Reneo and OnKure, Inc., a privately-held, clinical-stage biopharmaceutical company valued at $170 million that is focused on the development of novel precision medicines in oncology.
  • Duggal Visual Solutions receives investment from CortecJones Day advised Duggal Visual Solutions, Inc., a New York-based global leader in graphic printing, design services and visual solutions, in connection with a strategic investment by Cortec Group.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.